ITPR3-AS1
gene geneOn this page
Summary
ITPR3-AS1 (ITPR3 antisense RNA 1, HGNC:56127) is a long non-coding RNA gene on chromosome 6p21.31.
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:56127 |
| Approved symbol | ITPR3-AS1 |
| Name | ITPR3 antisense RNA 1 |
| Location | 6p21.31 |
| Locus type | RNA, long non-coding |
| Status | Approved |
| Entrez | 101929188 |
| RNAcentral | URS0000A7642C — lncRNA, 2176 nt, 1 organism(s) |
Gene structure
Transcript identifiers
Ensembl transcripts: 0
RefSeq mRNA: 0 — MANE Select: None
Canonical transcript exons
None — 0 exons
Expression profiles
Top tissues by expression
0 total, by Bgee expression score (0-100, higher = more expressed):
Regulation
Is transcription factor: no
Cross-species orthologs
0 orthologs
Protein
Protein identifiers
Canonical reviewed UniProt: None (reviewed: )
All UniProt accessions (0):
RefSeq proteins (0): (*=MANE)
Domains & families (InterPro)
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 1 (showing top):
chr6p21
GO Biological Process (0):
GO Molecular Function (0):
GO Cellular Component (0):
Protein interactions and networks
STRING
0 interactions, top by confidence (×1000):
IntAct
0 interactions, top by confidence:
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
0 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 0 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
80 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 6:33631538:C:A | acceptor_gain | 0.9700 |
| 6:33631731:A:T | donor_gain | 0.8500 |
| 6:33631536:ACC:A | acceptor_gain | 0.8200 |
| 6:33631537:C:G | acceptor_gain | 0.8200 |
| 6:33631412:ACAGG:A | acceptor_gain | 0.7700 |
| 6:33631543:T:G | acceptor_gain | 0.7300 |
| 6:33631536:A:AG | acceptor_gain | 0.7100 |
| 6:33631863:C:A | donor_gain | 0.7100 |
| 6:33631730:G:GT | donor_gain | 0.6800 |
| 6:33631632:G:T | donor_gain | 0.6700 |
| 6:33633460:G:GT | donor_gain | 0.6700 |
| 6:33631636:GGTT:G | donor_gain | 0.6400 |
| 6:33633490:G:T | donor_gain | 0.6200 |
| 6:33631865:C:G | donor_gain | 0.6100 |
| 6:33631411:TACAG:T | acceptor_gain | 0.5800 |
| 6:33631547:C:G | acceptor_gain | 0.5600 |
| 6:33631497:A:G | acceptor_gain | 0.5500 |
| 6:33631546:ACTGC:A | acceptor_gain | 0.5500 |
| 6:33632183:C:A | donor_gain | 0.5400 |
| 6:33631418:TAGGC:T | acceptor_gain | 0.5200 |
| 6:33631546:A:AG | acceptor_gain | 0.5200 |
| 6:33631862:T:TA | donor_gain | 0.5200 |
| 6:33631417:ATAGG:A | acceptor_gain | 0.5100 |
| 6:33631548:T:A | acceptor_gain | 0.5000 |
| 6:33631546:ACT:A | acceptor_gain | 0.4900 |
| 6:33631735:G:GT | donor_gain | 0.4900 |
| 6:33633510:G:A | donor_gain | 0.4900 |
| 6:33631414:AGGAT:A | acceptor_gain | 0.4500 |
| 6:33631542:A:AG | acceptor_gain | 0.4500 |
| 6:33631415:GGATA:G | acceptor_gain | 0.4400 |
AlphaMissense
0 scored. Top likely-pathogenic:
dbSNP variants (sampled 300 via entrez): RS1000760758 (6:33631048 C>A), RS1001608197 (6:33633714 G>A), RS1002561980 (6:33631677 T>C), RS1002800501 (6:33634096 C>A), RS1004662606 (6:33631608 A>C,G), RS1004853500 (6:33635020 C>T), RS1004898145 (6:33631392 G>T), RS1005442669 (6:33633676 G>A), RS1005576970 (6:33635480 G>A), RS1005804588 (6:33633424 C>T), RS1006407008 (6:33631861 G>C), RS1007125832 (6:33635333 T>A), RS1007397479 (6:33634700 G>A), RS1007847048 (6:33630874 C>T), RS1008382754 (6:33633362 A>T)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 0 entries
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.